title: A polypill is the solution to the pharmacological management of cardiovascular risk: no.
authors.affiliation: Department of Public Health and General Practice, University of Otago, Christchurch PO Box 345, Christchurch, New Zealand. les.toop@otago.ac.nz
authors.forename: Les
authors.initials: L
authors.lastname: Toop
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D006801:Humans; D008019:Life Style; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D017410:Practice Guidelines as Topic
chemical_list: D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors